GE Healthcare (GE) Receives FDA Clearance for AngioViz

GE Healthcare (NYSE: GE) announced the FDA clearance of AngioViz, an application that gives doctors a new visualization of vascular flow on a single image to help them make important decisions during complex interventional radiology procedures. AngioViz yields its information from Digital Subtraction Angiography (DSA), a technique commonly used to show the vascular anatomy.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• The West Can't Process Enough of This Critical Metal, and the Gap Doesn't Close by 2030
• The West Can't Process Enough of This Critical Metal, and the Gap Doesn't Close by 2030
• Holcim to acquire Fermacell from James Hardie for EUR 840M